Dadap, Baby Boy L.

HRN: 28-53-85  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/21/2026
02/28/2026
IV
16mg
Q24H
Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: